ROMIDEPSIN

Product NDC
70121-2250
11-digit product format
701212250
Labeler code
70121
Product ID
70121-2250_a007605f-1e3d-4174-b62c-999ebbe27ed5
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
ROMIDEPSIN
Dosage form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Labeler
Amneal Pharmaceuticals LLC
Application
ANDA219099
Marketing category
ANDA
Marketing start
2026-06-02
Substance
ROMIDEPSIN
Active strength
5 mg/mL
Pharmacologic classes
Bile Salt Export Pump Inhibitors [MoA], Histone Deacetylase Inhibitor [EPC], Histone Deacetylase Inhibitors [MoA], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A219099-001ROMIDEPSINROMIDEPSIN27.5MG/5.5ML (5MG/ML)SOLUTION / INTRAVENOUSRS2026-06-02

Orange Book exclusivity#

Current exclusivity rows page 1 of 1 · 1 matching rows.

Application-product, Exclusivity code, Expiration table
Application-productExclusivity codeExpiration
A219099-001CGT2026-12-07

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A219099-001ROMIDEPSIN27.5MG/5.5ML (5MG/ML)SOLUTION / INTRAVENOUSRS2026-06-0284e616aacf4f…
2026-08-18 06:07:402026-07A219099-001ROMIDEPSIN27.5MG/5.5ML (5MG/ML)SOLUTION / INTRAVENOUSRS2026-06-02caaa826d4ba7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219099-001ROMIDEPSIN27.5MG/5.5ML (5MG/ML)SOLUTION / INTRAVENOUSRS2026-06-02a50c72e98297…

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
CapturedEditionApplication-productExclusivity codeExpirationSource SHA-256
2026-09-14 22:38:342026-08A219099-001CGT2026-12-0784e616aacf4f…
2026-08-18 06:07:402026-07A219099-001CGT2026-12-07caaa826d4ba7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219099-001CGT2026-12-07a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
ROMIDEPSIN
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ROMIDEPSIN5 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
CX3T89XQBKInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2289413Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
61894b77-f29c-4a81-ad85-bd3a698233a4Available on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ROMIDEPSINROMIDEPSINAmneal Pharmaceuticals LLC61894b77-f29c-4a81-ad85-bd3a698233a42025-09-04Warnings, Adverse reactionsExact identifier
application applno (ANDA): 219099
application number: ANDA219099
ndc (product): 70121-2250

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
70121-2250-1701212250011 VIAL in 1 CARTON (70121-2250-1) / 5.5 mL in 1 VIAL1 vial2026-06-02NoNoCurrent